囊性纤维化患者的呼吸系统康复技术:系统审查和网络元分析的协议
Na Lin1, Xinyu Wang1, Yilong Tang1
1Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
BMJ open
|January 14, 2025
概括
本研究将使用网络元分析对囊性纤维化 (CF) 患者的呼吸道康复技术进行比较. 它旨在确定改善CF患者肺功能和运动能力的最有效策略.
科学领域:
- 肺部医学 肺部医学
- 遗传学 遗传学 是一个
- 康复科学 康复科学 康复科学
背景情况:
- 囊性纤维化 (CF) 是由CFTR基因突变引起的遗传疾病,影响呼吸和消化系统.
- 呼吸系统康复对于控制CF肺部症状和肺功能至关重要.
- 目前尚缺少一种最佳的,全球公认的CF呼吸系统康复方案.
研究的目的:
- 进行网络元分析,以评估和比较CF患者各种呼吸道康复技术的有效性.
- 确定最有益的干预措施,以改善CF的关键健康结果.
主要方法:
- 在多个数据库 (Medline,Embase,Cochrane,Web of Science,CINAHL,PEDro) 进行全面的搜索将持续到2024年9月.
- 纳入随机对照试验 (RCT) 和准RCT,比较气道清除,运动训练和启发性肌肉训练.
- 主要结局包括肺功能 (FEV1,FVC) 和运动能力 (VO2max,6MWT);次要结局包括生活质量,恶化,住院和不良事件.
主要成果:
- 数据将通过对联和网络元分析进行合成.
- 建议评估,开发和评价 (GRADE) 的评级方法将评估证据的质量.
- 结果将确定不同呼吸道康复策略的比较有效性.
结论:
- 这个网络的元分析将提供一个全面的对比呼吸系统康复技术的CF.
- 这些发现将为临床实践提供信息,并指导为CF患者制定最佳康复策略.
- 计划通过同行评审期刊和会议进行传播.
更多相关视频
相关概念视频
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
Chest Physiotherapy
377
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
377
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Cystic Fibrosis: Pathogenesis
184
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
184
Acute Respiratory Failure-III
154
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
154
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


